Title: Stricken language would be deleted from and underlined language would be added to present law.
Official Title: Stricken language would be deleted from and underlined language would be added to present law.
Number of Sections: 1
Source: versions - HB 1055
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
1 State of Arkansas As Engrossed: H1/30/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1055
4
5 By: Representatives J. Mayberry, Rye, Breaux, Springer
6 By: Senators C. Penzo, F. Love
7
For An Act To Be Entitled
8
9 AN ACT TO ESTABLISH COVERAGE DIAGNOSIS AND TREATMENT
10 TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE OR
11 OTHER DEMENTIA-RELATED DISEASE UNDER THE STATE AND
12 PUBLIC SCHOOL LIFE AND HEALTH INSURANCE PROGRAM; AND
13 FOR OTHER PURPOSES.
14
15
Subtitle
16
17 TO ESTABLISH COVERAGE DIAGNOSIS AND
18 TREATMENT TO SLOW THE PROGRESSION OF
19 ALZHEIMER'S DISEASE OR OTHER DEMENTIA-
20 RELATED DISEASE UNDER THE STATE AND
21 PUBLIC SCHOOL LIFE AND HEALTH INSURANCE
22 PROGRAM.
23
24 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
25
26 SECTION 1. Arkansas Code Title 21, Chapter 5, Subchapter 4, is amended
27 to add an additional section to read as follows:
28 21-5-425. Coverage for diagnosis and treatment of Alzheimer's disease
29 or other dementia-related disease — Legislative findings and intent — Rules.
30 (a) The General Assembly finds that:
31 (1) Alzheimer's disease is the seventh leading cause of death in
32 Arkansas according to the Centers for Disease Control and Prevention;
33 (2) The cost of managing the complications of late-stage
34 Alzheimer's disease, largely due to delayed diagnosis and access to
35 treatment, outweighs the cost of expeditious and effective treatment;
36 (3) The diagnosis and treatment of Alzheimer's disease or other
*ANS058*
01-30-2025 10:13:32 ANS058
As Engrossed: H1/30/25 HB1055
1 dementia-related disease should be a clinical decision made by a physician
2 based on evidence-based guidelines; and
3 (4) The United States Food and Drug Administration has granted
4 approval for treatments of patients in the early stages of Alzheimer's
5 disease.
6 (b) It is the intent of the General Assembly to provide coverage for
7 the diagnosis and treatment of Alzheimer's disease or other dementia-related
8 disease.
9 (c) Each state employee's and public school employee's health benefit
10 plan under the State and Public School Life and Health Insurance Program that
11 is offered, issued, or renewed on or after January 1, 2026, shall offer
12 coverage for the diagnosis and treatment of Alzheimer's disease or other
13 dementia-related disease as determined by a physician licensed to practice
14 medicine in this state and according to the standards or guidance established
15 by the United States Food and Drug Administration.
16 (d) The coverage and treatment of Alzheimer's disease or other
17 dementia-related disease offered under subsection (c) of this section shall:
18 (1) Be a treatment or medication that has been approved by the
19 United States Food and Drug Administration to treat or slow the progression
20 of Alzheimer's disease or other dementia-related disease;
21 (2) Include without limitation:
22 (A) Any diagnostic testing that is necessary for a
23 physician to determine the appropriate use of treatments and medications
24 under subdivision (d)(1) of this section; and
25 (B) All treatments or medications prescribed to slow the
26 progression of Alzheimer's disease or other dementia-related disease; and
27 (3) Not be subject to step therapy protocols.
28 (e) The State Board of Finance may promulgate rules to implement this
29 section.
30
31 /s/J. Mayberry
32
33
34
35
36
2 01-30-2025 10:13:32 ANS058
[DELETED:  A     EBL1   A T O P F   T T A R P P  B   S t  2 o  (   ( A   ( A t   (]
[DELETED:  H2 0 d b   ( a d  ( t d  ( p i c d m b  ( d   ( U o   (    ( p u    ( p   (  ( s  /     ]


================================================================================

Raw Text:
Stricken language would be deleted from and underlined language would be added to present law.
1 State of Arkansas As Engrossed: H1/30/25
A Bill
2 95th General Assembly
3 Regular Session, 2025 HOUSE BILL 1055
4
5 By: Representatives J. Mayberry, Rye, Breaux, Springer
6 By: Senators C. Penzo, F. Love
7
For An Act To Be Entitled
8
9 AN ACT TO ESTABLISH COVERAGE DIAGNOSIS AND TREATMENT
10 TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE OR
11 OTHER DEMENTIA-RELATED DISEASE UNDER THE STATE AND
12 PUBLIC SCHOOL LIFE AND HEALTH INSURANCE PROGRAM; AND
13 FOR OTHER PURPOSES.
14
15
Subtitle
16
17 TO ESTABLISH COVERAGE DIAGNOSIS AND
18 TREATMENT TO SLOW THE PROGRESSION OF
19 ALZHEIMER'S DISEASE OR OTHER DEMENTIA-
20 RELATED DISEASE UNDER THE STATE AND
21 PUBLIC SCHOOL LIFE AND HEALTH INSURANCE
22 PROGRAM.
23
24 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:
25
26 SECTION 1. Arkansas Code Title 21, Chapter 5, Subchapter 4, is amended
27 to add an additional section to read as follows:
28 21-5-425. Coverage for diagnosis and treatment of Alzheimer's disease
29 or other dementia-related disease — Legislative findings and intent — Rules.
30 (a) The General Assembly finds that:
31 (1) Alzheimer's disease is the seventh leading cause of death in
32 Arkansas according to the Centers for Disease Control and Prevention;
33 (2) The cost of managing the complications of late-stage
34 Alzheimer's disease, largely due to delayed diagnosis and access to
35 treatment, outweighs the cost of expeditious and effective treatment;
36 (3) The diagnosis and treatment of Alzheimer's disease or other
*ANS058*
01-30-2025 10:13:32 ANS058

As Engrossed: H1/30/25 HB1055
1 dementia-related disease should be a clinical decision made by a physician
2 based on evidence-based guidelines; and
3 (4) The United States Food and Drug Administration has granted
4 approval for treatments of patients in the early stages of Alzheimer's
5 disease.
6 (b) It is the intent of the General Assembly to provide coverage for
7 the diagnosis and treatment of Alzheimer's disease or other dementia-related
8 disease.
9 (c) Each state employee's and public school employee's health benefit
10 plan under the State and Public School Life and Health Insurance Program that
11 is offered, issued, or renewed on or after January 1, 2026, shall offer
12 coverage for the diagnosis and treatment of Alzheimer's disease or other
13 dementia-related disease as determined by a physician licensed to practice
14 medicine in this state and according to the standards or guidance established
15 by the United States Food and Drug Administration.
16 (d) The coverage and treatment of Alzheimer's disease or other
17 dementia-related disease offered under subsection (c) of this section shall:
18 (1) Be a treatment or medication that has been approved by the
19 United States Food and Drug Administration to treat or slow the progression
20 of Alzheimer's disease or other dementia-related disease;
21 (2) Include without limitation:
22 (A) Any diagnostic testing that is necessary for a
23 physician to determine the appropriate use of treatments and medications
24 under subdivision (d)(1) of this section; and
25 (B) All treatments or medications prescribed to slow the
26 progression of Alzheimer's disease or other dementia-related disease; and
27 (3) Not be subject to step therapy protocols.
28 (e) The State Board of Finance may promulgate rules to implement this
29 section.
30
31 /s/J. Mayberry
32
33
34
35
36
2 01-30-2025 10:13:32 ANS058

[DELETED:  A     EBL1   A T O P F   T T A R P P  B   S t  2 o  (   ( A   ( A t   (]
[DELETED:  H2 0 d b   ( a d  ( t d  ( p i c d m b  ( d   ( U o   (    ( p u    ( p   (  ( s  /     ]